Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- Check5 days agoChange DetectedThe clinical-trial record for the XMT-1536 study is displayed, including its study design, participant criteria, treatment arms, outcome measures, and record dates.SummaryDifference56%

- Check12 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page. The displayed site revision also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous study content. This indicates the study record is currently inaccessible.SummaryDifference20%

- Check61 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an underlying update to the page version behind the study details.SummaryDifference0.1%

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.